about
Therapeutic effect of hydrogen sulfide-releasing L-Dopa derivative ACS84 on 6-OHDA-induced Parkinson's disease rat modelHydrogen sulfide releasing aspirin, ACS14, attenuates high glucose-induced increased methylglyoxal and oxidative stress in cultured vascular smooth muscle cellsEfficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.S-diclofenac protects against doxorubicin-induced cardiomyopathy in mice via ameliorating cardiac gap junction remodelingACS6, a Hydrogen sulfide-donating derivative of sildenafil, inhibits homocysteine-induced apoptosis by preservation of mitochondrial function.Hydrogen sulphide-releasing diclofenac derivatives inhibit breast cancer-induced osteoclastogenesis in vitro and prevent osteolysis ex vivo.Dithiolethione compounds inhibit Akt signaling in human breast and lung cancer cells by increasing PP2A activityThe hydrogen sulphide-releasing derivative of diclofenac protects against ischaemia-reperfusion injury in the isolated rabbit heart.Effect of hydrogen sulphide-donating sildenafil (ACS6) on erectile function and oxidative stress in rabbit isolated corpus cavernosum and in hypertensive rats.H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and GDithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.Novel dithiolethione-modified nonsteroidal anti-inflammatory drugs in human hepatoma HepG2 and colon LS180 cells.Therapeutic potential of new hydrogen sulfide-releasing hybrids.New sulfurated derivatives of cinnamic acids and rosmaricine as inhibitors of STAT3 and NF-κB transcription factors.Methanethiosulfonate derivatives as ligands of the STAT3-SH2 domain.Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.Effect of S-aspirin, a novel hydrogen-sulfide-releasing aspirin (ACS14), on atherosclerosis in apoE-deficient mice.Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7-chloro-4-aminoquinoline.Dithiolethiones inhibit NF-κB activity via covalent modification in human estrogen receptor-negative breast cancer.Organosulfur derivatives of the HDAC inhibitor valproic acid sensitize human lung cancer cell lines to apoptosis and to cisplatin cytotoxicity.New aryldithiolethione derivatives as potent histone deacetylase inhibitors.Effects of hydrogen sulfide-releasing L-DOPA derivatives on glial activation: potential for treating Parkinson disease.New histone deacetylase inhibitors as potential therapeutic tools for advanced prostate carcinoma.[4-(2H-1,2,3-benzotriazol-2-yl)phenoxy]alkanoic acids as agonists of peroxisome proliferator-activated receptors (PPARs).Modulation of angiogenesis by dithiolethione-modified NSAIDs and valproic acid.Synthesis and Antiplasmodial Activity of Novel Chloroquine Analogues with Bulky Basic Side Chains.Novel antimalarial aminoquinolines: heme binding and effects on normal or Plasmodium falciparum-parasitized human erythrocytes.High antiplasmodial activity of novel plasmepsins I and II inhibitors.Anethole dithiolethione lowers the homocysteine and raises the glutathione levels in solid tissues and plasma of rats: a novel non-vitamin homocysteine-lowering agent.Activity of a new hydrogen sulfide-releasing aspirin (ACS14) on pathological cardiovascular alterations induced by glutathione depletion in rats.Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.Targeting the plasmepsin 4 orthologs of Plasmodium sp. with "double drug" inhibitors.Hydrogen sulfide-releasing NSAIDs attenuate neuroinflammation induced by microglial and astrocytic activation.Benzimidazole derivatives endowed with potent antileishmanial activity.In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage Antimalarial.Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation.Novel amodiaquine congeners as potent antimalarial agents.Exogenous hydrogen sulfide inhibits superoxide formation, NOX-1 expression and Rac1 activity in human vascular smooth muscle cells.New sulfurated derivatives of valproic acid with enhanced histone deacetylase inhibitory activity.Atovaquone-statine "double-drugs" with high antiplasmodial activity.
P50
Q28485947-3C3EFE7F-F83D-409B-A9AB-25AA080407DFQ28539333-1DEBE7BF-656D-44C3-920A-73267AA12BFCQ33560026-ABEF32BF-DDB0-4550-BB5C-4AC69A5B6D19Q34062431-F62366EC-EBE7-4FCB-AE6A-28B351750E7AQ34092938-4B62E089-0F4B-419D-BFA1-EEFEEBBC37D6Q36025402-7F71CC86-B65F-4C4A-9FF5-2E005E4FA017Q36321491-442620C9-1BA8-433B-925A-AC406DA0226DQ36381503-92E916BE-7C29-42CF-9A63-5E851CCD1B2EQ36682260-7DB92B3C-D5B8-4D39-BF35-D9939988840DQ37002373-22A44C89-0EB3-4905-B4CC-29A72D118BC8Q37328516-DEB0356E-E68C-4A6A-9167-01E46CC195D7Q37371516-CE88928A-C316-467C-9635-E5851567667EQ37960619-B7752036-B89D-44A7-9BB9-E78DA71E287AQ38696518-2DE6CBE3-B01E-47FB-8502-630840A984B1Q38720827-BED92EB1-8588-4000-B078-BD88916FCEEEQ38948242-001C39A9-EC43-4871-9777-7A4FC5F990B9Q39255899-A414D8C5-17CC-4730-9B25-52A1DD3D7220Q39292028-C045A570-14E9-4701-AF91-AF9C7E9A31D9Q39375950-8C4EE27E-0C22-4010-A8AB-85F1A2C93034Q39418780-CEC57808-62D6-4061-B581-ADA5E3C86140Q39688598-4FEF88C8-6CDA-42E0-9074-6FCEEAB392F6Q39718802-F7E3B860-FB42-465F-A83E-02477CD4909CQ40014273-4314E009-8F15-457E-80D8-438FCF67EDB5Q40189375-6CC4D18B-B215-4A61-B631-F161CAB7B21BQ41556578-CB78F761-C81A-45F9-A1F3-27853B33A3BFQ41917145-897D1DDE-A8B5-45B7-89FF-D30B873A449AQ41937826-4266EECD-50EB-4DCA-B785-AF0555F5D302Q41944053-1A567978-8DD4-41DD-8120-C0B06BCBEC57Q42120299-7876F841-EE54-4A44-99AA-8569FE30AD16Q42913506-45B78661-7897-4BE6-BB29-224CD42845BAQ43051519-42555CA1-89D7-4E83-BC44-C5CB1B3FB57AQ44122579-5801DA34-04CE-4D06-BD71-852C23CF37B1Q45959353-886C295F-0BDB-4412-9FE3-A62D87FEF4EEQ46242806-E316B0CB-62BE-4F4F-879C-7EE4B15C741DQ46250299-362DE688-FB52-4EE2-AF5C-40A19ACF2DF5Q46445452-1CE549A3-FE7E-45FE-B0F9-2A1D579625C3Q46533648-495F881A-BBAB-45AB-887D-279C474B6E50Q46607267-4652CE08-9B1C-4898-B382-D369D7E83857Q46737727-FDD72E16-B521-4836-876E-6BB7E5B53021Q46862144-20F5AC2E-5405-4B00-B2DE-C86C131C48C5
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Anna Sparatore
@ast
Anna Sparatore
@en
Anna Sparatore
@es
Anna Sparatore
@nl
Anna Sparatore
@sl
type
label
Anna Sparatore
@ast
Anna Sparatore
@en
Anna Sparatore
@es
Anna Sparatore
@nl
Anna Sparatore
@sl
prefLabel
Anna Sparatore
@ast
Anna Sparatore
@en
Anna Sparatore
@es
Anna Sparatore
@nl
Anna Sparatore
@sl
P1053
J-8634-2015
P106
P1153
7003353313
P21
P31
P3829
P496
0000-0003-2135-2649